Bonus shares at Antibiotice

The shareholders of Iasi-based drug maker Antibiotice at the end of the month will discuss a share capital increase by issuance of bonus shares. The share capital of the company should be increased by 34bn ROL, accounting for the dividends the shareholders endorsed early in the year, which Antibiotice no longer disbursed. The shareholders registered by November 15 are supposed to get one bonus share for every 11 shares held, while the share capital should go up to 404bn ROL. Antibiotice did the same with the 2002 profit-related dividends the shareholders had allocated, because of the arrearage in the health care system. It was last trading for 3,890 ROL on the Bucharest Stock Exchange on Friday. Antibiotice is the only drug maker still owned by the State, which holds 53% in the company through the Health Ministry. ZF